Back to companies

Roivant Sciences Ltd.

ROIVGBNASDAQPharmaceuticals & Healthcare

Roivant Sciences Ltd.

Revenue
$8.3mn
YoY -71.6%
Operating income
-$515.1mn
FY2026
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API